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Abstract
Objectives: Performance-based outcome measures (PBOM) are suggested to evaluate
change in function during rehabilitation after total knee arthroplasty (TKA). The purpose
of this study was to evaluate the measurement properties of the 30-Second Chair Stand
Test (30CST) and 10-Metre Walk Test (10MWT) in patients following TKA.
Methods: Eighty-three patients completed two PBOM on three occasions following
surgery. Patients also completed the Western Ontario and McMaster Universities
Osteoarthritis Index and Global Rating of Change (GRC).
Results: Intraclass correlation coefficients ranged from 0.82 to 0.96. The standard errors
of measurement at 6 and 12 weeks postoperative, respectively, were: 30CST ±0.67 and
±0.79, 10MWT ±1.05 and ±0.57. Minimal detectable changes (90% confidence level)
were: 30CST ±1.56 and ±1.84, 10MWT ±2.43 and ±1.32. Correlations between change in
PBOM and GRC ranged from -0.16 to 0.34.
Conclusions: These results support the reliability, validity and clinical use of the 30CST
and 10MWT during rehabilitation following TKA.

Key Words: performance-based outcome measures, rehabilitation, total knee
arthroplasty, psychometric measurement properties
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Summary for Lay Audience
Rehabilitation is important to achieve optimal results following total knee arthroplasty
(TKA). The goal of rehabilitation is to maximize functional independence. One method
to assess outcomes is to select appropriate measures that quantify improvements in
physical function. Performance-Based Outcome Measures (PBOM) of physical function
are more likely to exemplify a change in function than self-report measures alone. This
thesis evaluated the measurement properties of the 30-Second Chair Stand Test (30CST)
and 10-Metre Walk Test (10MWT) in patients following total knee arthroplasty. The
results of the study support the reliability, validity, and clinical use of the 30CST and
10MWT during rehabilitation following surgery. Integrating reliable and valid PBOM
into clinical practice is essential for patients, physiotherapists, and surgeons to measure
change in function during rehabilitation. This protocol may ultimately assist with clinical
decision-making and guide best practice.
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Chapter 1
Introduction
According to the Canadian Institute for Health Information, more than 70,000 knee
replacements were performed in Canada in 2017-18. Approximately 65,000 were
primary replacements. These numbers have increased by 17% in the last 5 years.1
Similar trends in annual growth in incidence of total knee arthroplasty (TKA) have been
observed world-wide.2 In 2011, Kurtz et al observed a 27-fold range of TKA utilization
rates between 18 different countries, including the United States, Denmark, the
Netherlands and Australia. They estimated 1,324,000 primary and revision TKA
procedures are completed globally each year, with this number expected to continue to
rise.2 The 25-year survivorship for total knee arthroplasty is estimated to be 82%.3
Despite overall favourable results many studies estimate that up to 20% of patients are
dissatisfied following a total knee arthroplasty. Unfulfilled expectations are strongly
associated with poor satisfaction.4,5
Rehabilitation is important to achieve optimal results following total knee arthroplasty.
The goals of rehabilitation focus on maximizing functional independence and minimizing
complications.6 Systematic reviews conclude that no one approach is superior when
recommending duration and delivery of care.7 One method to assess outcomes is to select
appropriate measures that quantify improvements in physical function. Self-report
measures are commonly used following surgery due to the ease of administration;
however, evidence suggests that these types of measures may fail to capture important
functional improvements following TKA. Self-report measures provide an analysis of a
patient’s perception of their functional abilities. A patient’s perception of task
importance can influence their response 8 along with difficulty separating pain from the
ability to perform the activity.9 Because of this, performance-based outcome measures
(PBOM) of physical function are more likely to exemplify a change in function than selfreport measures alone.9 Previous research has examined the association between selfreport and performance-based measures and found correlations ranging between 0.02 and
0.59.10
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Recommended performance-based measures to assess function in people with hip and
knee osteoarthritis, those awaiting joint replacement, and following joint replacement
have been outlined by various groups such as The Osteoarthritis Research Society
International (OARSI), Rehabilitative Care Alliance (RCA) and various clinical
researchers.11–13 Although the recommended measures may vary slightly from group to
group, they often include a measure of gait speed and lower extremity functional strength
and endurance integrated into typical activities relevant to the patient population such as
climbing stairs, getting in and out of a chair and walking.
OARSI’s recommended minimum set of PBOM include: the 30-second chair stand test,
40 metre fast-paced walk test and stair climb test.12 Due to the complexity of the 40 metre
fast-paced walk test and identified limitations, the 10 metre fast-paced walk test was
recognized as an acceptable alternative. These measures focus on a population diagnosed
with osteoarthritis (OA), as well as those following joint replacement. The psychometric
properties of these measures have been evaluated extensively in those with knee OA who
may be awaiting TKA, however, to our knowledge, the reliability and validity has not
been examined in the TKA population during postoperative rehabilitation. For this study
evaluating measurement properties and establishing point estimates at different points in
recovery was an important part of the research design. Change in functional status
following TKA is variable and each patient’s trajectory is unique. Although potential for
recovery following TKA can occur over a 12 month period, the greatest improvement in
physical impairments and activity limitations occurs in the first twelve weeks or three
months.14,15 As the rate of change in function is greater in the initial stage of recovery; we
cannot assume that the measurement properties at different time points during this phase
are identical.
Integrating reliable and valid PBOMs into clinical practice is essential for patients,
physiotherapists, and surgeons to measure change in function during postoperative
rehabilitation following TKA and may ultimately assist with clinical decision-making and
guide best practice in rehabilitation.
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This study will evaluate the measurement properties of the 30-Second Chair Stand Test
(30CST) and 10-Metre Walk Test (10MWT) in patients during postoperative
rehabilitation following TKA.
Objectives:
1) examine test-retest reliability of the 30CST and 10MWT.
2) evaluate the longitudinal validity of the 30CST and 10MWT.
3) explore the concurrent validity of the 30CST,10MWT and the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC) score.
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Chapter 2
Literature Review
Osteoarthritis
Osteoarthritis is a common degenerative joint disease. Not only does it target the
articular cartilage it also affects the surrounding tissue structures. Chronic low-grade
inflammation contributes to the initiation and progression of the disease.16,17 Knee OA is
characterized by progressive loss and destruction of articular cartilage, thickening of
subchondral bone, formation of osteophytes, inflammation of the synovium, degeneration
of ligaments and menisci and hypertrophy of the joint capsule leading to loss of normal
joint function.17,18 The result of this disease can be characterized by joint pain, swelling
and stiffness that leads to activity limitations, participation restrictions, sleep interruption,
fatigue, depression, anxiety, loss of independence and overall decreased quality of life.19
OA affects over 250 million people globally or 4% of the world’s population.
Worldwide estimates are that 9.6% of men and 18% of women over 60 years of age have
symptomatic OA.19,20 The prevalence of OA continues to increase with age, as does the
increase in risk factors for OA such as obesity.19,21
The economic and health burden that OA presents is significant and continues to grow
with the aging population and increased demands for effective interventions. Sharif et
al.,22 estimate that the total direct cost of OA from 2010 to 2031 in Canada will rise from
2.9 billion to 7.6 billion. These costs include: hospitalization, outpatient services,
alternative care/out of pocket, drugs, rehabilitation and side effect of drugs. The size of
the working population with OA will also rise leading to increased productivity costs of
work loss equaling 17.5 billion.23
In 2016 OARSI submitted a document to the U.S Food and Drug Administration titled
“Osteoarthritis: A Serious Disease”.19 Along with pain, loss of function and increased
mortality OA is also associated with increased comorbidity.19 Cardiovascular disease,
diabetes mellitus and hypertension are a few of the more prevalent comorbidities in
populations with OA.19,24,25 The rationale behind this link may be due to similar risk
4

factors across the conditions, such as age and obesity and the fact that pain and decreased
mobility associated with OA limits a person’s ability to self-manage conditions such as
diabetes and hypertension as it impacts physical activity levels.19,26–29
Treatment of Knee Osteoarthritis Including Total Knee Arthroplasty
Osteoarthritis is a progressive disease, but it is most definitely not predictable.
Systematic reviews and meta-analysis have highlighted prognostic factors that may
predict the progression of OA. Patient characteristics included in these predictors were:
age, varus alignment, presence of OA in multiple joints, radiographic features and body
mass index (BMI). Participation in physical activity was not associated with progression
of OA.30
Currently, there is no cure for osteoarthritis. Treatment is targeted at managing
symptoms, including pain and loss of function.31
Pharmacological interventions such as acetaminophen, non-steroidal anti-inflammatory
drugs (NSAIDs) and intra-articular injections have all been found to be superior to
placebo with respect to decreasing pain and improving function.32 Although these
treatments may be beneficial in symptom management, the adverse effects associated
with these interventions are significant. NSAIDs alone have been shown to increase the
risk of serious conditions such as peptic ulcer bleeds, cardiac and kidney disease.33–36
Weight loss has also been determined to be an effective intervention for those with knee
OA. A reduction in weight of 5-10% has been associated with a significant decrease in
pain and disability.37,38 Zheng et al examined the association between an increase in
weight and risk of OA. Their systematic review concluded that in an increase in BMI of
5kg/m translated into a 35% increased risk of developing knee OA.39
In 2013, Uthman et al., undertook a systematic review and meta-analysis. Their objective
was “To determine whether there is sufficient evidence to conclude that exercise
interventions are more effective than no exercise control and to compare the effectiveness
of different exercise interventions in relieving pain and improving function in patients
with lower limb osteoarthritis.” They concluded that enough evidence had been
5

accumulated to show significant benefit of exercise over no exercise in patients with OA.
The authors also concluded that further studies would unlikely change this result.
Exercise prescription targeting increase in strength, flexibility and aerobic capacity are
likely to provide the most effective results.40
In 2015, Fransen et al., completed a Cochrane systematic review concluding, exercise is
the only intervention for knee OA whose efficacy is supported by over 50 randomized
controlled trials and recommended by several best-practice guidelines.41
Inclusion of neuromuscular exercises into a comprehensive exercise program with the
goal of improved sensorimotor control and functional stabilization of joints has proven to
be effective in symptom management in those with OA42. These exercises involve
multiple joints and muscle groups and are performed in functional weight bearing
positions. Emphasis is placed on quality of movement and alignment during the activity.
First line and second line treatments including: education, exercise, weight control,
medication, assistive devices and physiotherapy are all effective management strategies
for those with knee OA.31,43 For many, this is all that will be required to control
symptoms and maintain function. For those who continue to experience significant pain,
loss of function and decreased quality of life, a total knee replacement can be a beneficial
and cost-effective treatment for end-stage OA.15 Appropriateness of surgery must take
into consideration the patient’s current state, disease progression and expected benefit
from the proposed surgery.
According to the Canadian Institute for Health Information, more than 70,000 knee
replacements were performed in Canada in 2017-18. Approximately 65, 00 were primary
replacements. These numbers have increased by 17% in the last 5 years.1 The 25-year
survivorship for total knee arthroplasty is estimated to be 82%.3 Despite overall
favourable results many studies estimate that up to 20% of patients are dissatisfied
following a total knee arthroplasty. Unfulfilled expectations are strongly associated with
poor satisfaction.4,5 Identifying gaps in expectations would enable clinicians to provide
better preoperative education to help patients develop realistic expectations for recovery
which may improve outcomes.
6

Total Knee Arthroplasty Rehabilitation Research
Defining optimal rehabilitation following total knee arthroplasty continues to be an
ongoing challenge for researchers and clinicians alike. As different measures of outcome
are utilized; when comparing one treatment protocol to another it can be difficult to
integrate the results and come to an agreed upon best practice guideline. Patient factors,
such as expectations, pre-operative function and comorbidities also need to be considered
when establishing a treatment plan and delivery of care. It is reported that functional
improvements can continue to be observed for up to one year following TKA, however
many rehabilitation programs do not follow patients past the twelve-week mark.44–46
Westby et al.,47 led a group of 42 experts, including clinicians, researchers and patients
through a Delphi process to reach a consensus on best practices for post-acute
rehabilitation following total knee arthroplasty. Consensus was reached on
recommendations such as: patients should be offered structured-post acute rehabilitation,
the rehabilitation should be offered by trained professionals and care should be under
direct health professional supervision. Recommended interventions included: therapeutic
and functional exercise, gait training, cardiovascular training, thermal modalities, manual
therapy and patient education. Consensus was not reached when it came to number of
weeks of treatment, frequency of visits and overall number of treatment sessions. It was
agreed, by 97%, that body structures and function outcomes be routinely assessed.
Recommendations for appropriate tools to assess these outcomes were also highlighted.
Timed walk, single leg static balance, repeated stands and timed stair climb were
included in the performance based outcome measures. The WOMAC, Lower Extremity
Functional Scale (LEFS) and Numeric Pain Rating Scale (NPRS) were among the selfreport measures agreed to be the best to use.
The Rehabilitative Care Alliance in Ontario, funded by the 14 Local Health Integrated
Networks (LHIN), created a best practice framework outlining recommended ambulatory
rehabilitation care for patients with primary total knee replacement. The group advocated
for rehabilitation to be initiated within 7 days of discharge. Duration of treatment would
depend on achievement of goals and plateaus but exercises to achieve range of motion
(ROM) and function throughout the first 12 weeks following surgery should be provided
7

with a frequency of 2-3 times per week. It was stated that regarding function, ROM and
health-related quality of life, group-based therapy models provided similar outcomes to
1:1 therapy. In planning for discharge, patients are to be provided with a home program
and education in a continuing program in the community. To measure progress, ROM,
strength and gait speed are to be assessed along with one self-report measure and at least
one performance-based outcome measure.13
Buker et al.,48 conducted a prospective randomized trial comparing supervised
physiotherapy and a standardized home program on functional status in 34 patients
following a total knee arthroplasty. The WOMAC was used for assessment of physical
function. Secondary measures included pain on a visual analog scale, ROM, Beck
Depression Inventory Scale and the Short Form 36 (SF36) to assess overall quality of
life. The study found no difference between the two groups with respect to functional
status. No performance-based measures were included for the assessment of functional
status.
Bruun-Olsen et al.,49 conducted a randomized controlled trail (RCT) to compare the
immediate and long-term effects of a walking-skill program and usual physiotherapy
care in 57 patients following primary total knee arthroplasty. The walking-skill group
program included functional training in weight-bearing positions and participating in
activities such as, climbing stairs, walking at different speeds and maneuvering around
and over obstacles. The usual physiotherapy care included ROM and strength exercises
mostly performed in sitting, with little emphasis on a functional component. Both groups
received 12 supervised sessions over the course of 6 weeks. Outcome measures included:
the 6 minute walk test (6MWT), timed stair climbing, timed stands, figure-of-eight test,
index of muscle function, active knee ROM, Knee Injury and Osteoarthritis Outcome
Score and self-efficacy score. The results reported a significant difference between
groups favoring the walking-skills group with respect to the primary outcome measure of
the 6MWT. This difference was noted at all testing time points which included 9 months
after the intervention ended, at 12 months following surgery.
Harmer et al.,50 conducted a RCT comparing land-based versus water-based rehabilitation
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in 102 patients following total knee arthroplasty. Groups were compared at 8 and 26
weeks following surgery using the 6MWT, stair climbing power and WOMAC. Pain was
recorded on VAS along with passive knee ROM and knee edema. All outcomes
improved in both groups over time. Although there was a statistically significant
difference, favouring the water-based group in stair climbing power, WOMAC stiffness,
WOMAC function and knee edema, these were felt to not be clinically important
differences. This would lead us to conclude that both land-based and water-based
rehabilitation provides comparable improvements following TKA.
In recent years two systematic reviews have examined exercise after TKA. In 2013,
Pozzi et al.,51 published a systematic review of 19 controlled trials identifying four
categories of post-operative intervention of importance to discuss: strengthening
exercises, aquatic therapy, balance training and clinical environment. The authors
provided recommendations for optimal outpatient physiotherapy protocols based on their
findings. Based on the literature it is recommended that strengthening and functional
exercises, both land-based or water-based are appropriate. Rehabilitation performed in a
clinic may provide the best long-term outcomes. Studies that conclude that outpatient
physiotherapy does not offer long-term benefit often used inadequate methodology to
support their results. There was some agreement that alternate forms of rehabilitation,
such as home based or telerehabilitation can provide improved outcomes for those who
may not be able to access outpatient rehabilitation facilities. Consistently it was noted
that “usual care” or “standard physical therapy” often lacked the detail surrounding
treatment parameters making it difficult to compare treatment groups. With each study
established measures were used to assess change in selected outcomes. Performancebased measures such as the timed up and go (TUG), stair climb test, 6MWT, gait speed,
and 30CST were often used to evaluate functional change. The WOMAC, Oxford Knee
Score and SF-36 provided information regarding self-reported change.
In 2015, Artz et al.,52 completed a systematic review and meta-analysis exploring the
effectiveness of physiotherapy exercise following total knee replacement. The review
included 18 randomized control trials with a total of 1739 patients following TKA.
Outcomes measures used included both performance-based and self-report measures of
9

function similar to the Pozzi et al.,51 systematic review. Of note, 11 of the 18 RCTs were
used in both papers. Results of the meta-analysis were reported as standardized mean
differences (SMD). Overall, compared to those receiving minimal physiotherapy, those
provided with physiotherapy exercises had improved physical function at 3 to 4 months
with a SMD of -0.37 (95% confidence interval (CI) -0.62 to -0.12) concluding that those
who received physiotherapy exercises had a greater improvement in physical function
than those who received minimal or no physiotherapy exercise.
After review of the literature it is clear that although there are some common themes
highlighted in research, there is still no clear formula when it comes to rehabilitation
following TKA. Patient and environmental factors are essential to consider when
establishing a treatment plan.
Many studies have integrated both self-report and performance-based measures into their
outcomes, including the 30CST and gait speed, allowing them to capture perceived and
true functional change when comparing groups. There continues to be a growing body of
evidence that self-report measures are influenced by the patient’s experience during
activities, such as increased pain or rate of perceived exertion and therefore can provide
an imprecise representation of their true functional capacity.53,54 Therefore, in addition to
self-report measures, performance-based measures are essential to use when measuring
functional improvement following TKA.8,9,53,55
Measurement Properties
When selecting outcome measures to evaluate functional change, it is crucial that the
measure possess adequate measurement properties. Acceptable reliability, validity and
ability to detect change are required in order to provide accurate and meaningful results.
To be useful outcome measures should allow for improvement and deterioration in a
patient’s functional status to be revealed.56

10

Reliability
A reliable measure must possess precision, or the ability to provide consistent values for
repeated measurements with minimal error in measurement. It must also be able to
differentiate between individuals who are being measured with the tool. With this in
mind reliability is often communicated as relative reliability or absolute reliability.
Relative reliability allows us to explore the measure’s ability to differentiate between
individuals. Relative reliability is calculated as the ratio of the true variance to the total
variance. The true variance can also be termed as between-patient variance. The total
variance is the sum of the true variance and the error variance, or within-patient
difference.56 Relative reliability is expressed with an Intraclass Correlation Coefficient
(ICC) with values varying from 0.00-1.00. An ICC closer to 1.00 indicates higher
reliability. Portney and Watkins suggest that values less than 0.50 reflect poor reliability,
0.50 to 0.75 suggest moderate reliability and ICC values greater than 0.75 reflect good
reliability.57 Similarly, Fleiss describes values from 0.40 to 0.75 as fair to good.58 When
evaluating relative reliability the ICC is the superior coefficient to use rather than Pearson
product moment correlation. Association between two sets of data determines
correlation. Pearson’s can tell us how the scores vary together, but does not provide
information on the agreement between the score.56
Absolute reliability interprets the error associated with an individual’s score at a single
point in time. The measurement error is reported in the same units as the original
measurement unlike the ICC. This is often expressed as the standard error of
measurement (SEM). The SEM is calculated as standard deviation(SD)√ (1-ICC). In
order to establish if true change has occurred in a score rather than change due to error in
measurement the Minimal Detectable Change (MDC) can be calculated using the SEM.
Calculating an estimate of the Minimal Detectable Change at 90% confidence level
(MDC90) is achieved by multiplying the SEM by √2 and the z value for 90% confidence
(1.64).57
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Validity
Validity refers to the extent that a measure actually measures what it is intended to
measure. A valid measure also allows us to make inferences from test scores that may
assist us in clinical decision-making. Portney and Watkins state that a measure may be
used for discriminative, evaluative or predictive purposes. Is the measure able to
discriminate among individuals with and without a condition or trait? Can the measure
evaluate change between two test occasions? Finally, can we make predictions
surrounding prognosis or function based on a measures score? These are related to the
validity of a measure.57
When examining validity, the magnitude and direction of the relationship between two
measures is often studied using correlation analysis. When evaluating continuous
interval or ratio data the most common measure of correlation is the Pearson product
moment correlation (r). If the data being analyzed is ranked or ordinal a Spearman rank
correlation co-efficient is used (rs). Correlation values are reported from 0.00 (no
correlation) to 1.00 (perfect correlation).57 Portney and Watkins suggest, “correlations
ranging from 0.00 to 0.25 suggest little or no relationship; those from 0.25 to 0.50
suggest a fair degree of relationship; values of 0.50 to 0.75 are moderate to good; and
values above 0.75 are considered good to excellent”.57 The direction of the relationship
between the two measures will be represented by a + or - sign. For example, if one
variable increases as does the other a positive (+) correlation occurs. If one variable
increases while the other decreases a negative (-) correlation will be reported.
Four types of validity are described in the literature: face validity, content validity,
criterion validity and construct validity.56
Face validity indicates that a test appears to test what it is supposed to. This is the least
rigorous form of validity and is often established through observation.
Content validity refers to the extent that the measure incorporates a comprehensive
sample of items with respect to what is being evaluated. For example, if lower extremity
12

function is the topic of interest, the measure should encompass multiple tasks that relate
to the lower extremity.
Criterion validity is the most objective approach to validity. It examines the measure’s
ability to predict results obtained using another measure. The measure being examined is
compared to a gold standard or established measure that is already validated. The scores
on the two measures can then be correlated to each other to determine if the new measure
could be used as an alternate for the other validated measure it is tested against. Criterion
validity can be divided into concurrent validity and predictive validity. Concurrent
validity is studied when the two measures are administered at approximately the same
time. Prescriptive validity evaluates a measure’s ability to predict a future criterion score
or outcome.
Construct validity is applied in the absence of a gold standard. Here theories are
formulated and validity is evaluated based on the extent to which the measure produces
results in line with the proposed theories. Within the confines of construct validity also
discussed is cross-sectional and longitudinal validity, convergent and discriminant
validity, known-groups validity, sensitivity to change and responsiveness.
Cross-sectional validity48 evaluates two measures administered at a single point in time
and the association, or correlation between the scores on that one occasion. Longitudinal
validity examines the association between the change score of the validated measure and
the change score of the new measure being studied. Convergent validity indicates that
two measures that are thought to test the same thing should provide similar results and be
highly correlated. Measures that test different attributes should yield low correlation or
different results indicating adequate discriminant validity. Known-groups validity
examines two or more distinct groups. It is anticipated that the measure will be able to
distinguish between groups that possess a certain attribute or level of attribute.
Longitudinal validity describes the extent to which a measure evaluates constructs related
to change. Sensitivity to change is the often simply referred to as the ability of a measure
to detect change over time. Coefficients used to express sensitivity to change can include
Effect Size (ES) and Standardized Response Mean (SRM). ES is calculated by dividing
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the mean change score by the standard deviation of the baseline score. Cohen describes
interpretations of ES as scores below 0.2 are small, 0.5 is considered moderate and 0.8 is
considered large.56 SRM is calculated by dividing the mean change by the standard
deviation of the change scores. A SRM > 1 indicates that the change could be detected
over the variability.56 Responsiveness is the ability of a measure to detect clinically
meaningful change over time. Liang states “sensitivity to change is a necessary but
insufficient condition for responsiveness”. What constitutes a clinically important
change can vary depending on the situation and the interpretation of the individual.59
Standardized Performance-Based Outcome Measures used in Total Knee Arthroplasty
Performance-based outcome measures play an important role in measuring functional
change and outcome following TKA. The relationship between a patient’s self-efficacy
in performance of function and these measures is strong and mitigates the individual’s
inability to discriminate between pain and their ability to perform the task that can often
be associated with self-report measures of function.9,53,60
Recommended performance-based measures to assess function in people with hip and
knee osteoarthritis, those awaiting joint replacement and following joint replacement
have been outlined by various groups such as The Osteoarthritis Research Society
International (OARSI), Rehabilitative Care Alliance (RCA) and various clinical
researchers.11–13 Although the recommended measures may vary slightly from group to
group, they often include a measure of gait speed and lower extremity functional strength
and endurance integrated into typical activities relevant to the patient population such as
climbing stairs, getting in and out of a chair and walking.
Groups such as OARSI and the RCA, recommend a minimum set of self-reported
outcome measures and PBOM. These measures focus on a population diagnosed with
osteoarthritis (OA), as well as those following joint replacement. Although the
psychometric properties of these measures have been evaluated extensively in those with
knee OA who may be awaiting TKA, to our knowledge, the reliability and validity has
not been examined in the TKA population during postoperative rehabilitation.
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Dobson et al12 proposed a recommended set of performance-based measures to use in
people diagnosed with hip and knee osteoarthritis or following joint replacement. A
survey of experts and systematic review facilitated the process and measures were
selected based on their measurement-property evidence, feasibility of the test, scoring
method and expert consensus. This process resulted in a recommended set of
performance-based measures including: the 30CST, 40 m Fast-paced Walk Test
(40FPWT), Stair Climb Test, TUG and 6 Minute Walk Test (6MWT). The first three of
the mentioned tests were recommended as a minimum core set. As a follow up to these
recommendations, due to the complex nature administering the 40FPWT and scoring the
11 Step Stair Climb Test, the 10 Metre Fast-paced Walk Test and 20-second stair climb
test were suggested as alternatives.61
The Total Joint Arthroplasty and Outcome Measures (TJAOM) Knowledge Translation
Taskforce, led by Dr. Marie Westby, has created a toolkit to provide clinicians with
outcome measures for use along the continuum of care for patients before and after
arthroplasty.11 Prior to the creation of this toolkit McAuley et al.,62 surveyed Canadian
Physiotherapists about their experience using outcome measures in total hip and knee
arthroplasty patients. Familiarity with tests, current use and potential for future use were
explored. A secondary aim of the study was to understand clinical issues and barriers to
using outcome measures in various practice settings. A majority of the respondents
reported using more than one outcome measure. Familiarity was greatest with the TUG,
Single Leg Stance Test and 6MWT followed by the Sit to Stand Test and Walking Speed
Test. Beliefs regarding value of using a standardized tool, varying patient populations,
phase of recovery, care setting and availability of tools were all noted as concerns and
potential barriers to implementing appropriate outcome measures into their current
practice.
The recommendations outlined in the TJAOM tool kit included outcome measures to be
used along the total joint arthroplasty continuum: Pre-operative, Acute, Post-acute and
Active Living. Pre-operative was defined as moderate to advanced OA. Acute is during
the hospital stay. Post-acute refers to the outpatient/home therapy setting and active
living would be defined as 1 year following surgery and onwards. With the exception of
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the acute phase, the recommended performance-based outcome measure included:
30CST, Gait speed (self-selected), Stair climb test, Single leg stance test (30 seconds),
6MWT, TUG and functional reach.
Sit to stand and walking tests have been used and are recommended to measure
performance in both patients with OA who may be awaiting joint replacement and those
following joint replacement surgery.9,53,63,64 Not only can these measures be used to track
progress with functional change, they may also assist in clinical decision making, goal
setting and communication with both patients and other health care providers.62
Reliability of Sit to Stand Test/Walk Tests
Gill et al.,63 investigated the intra-rater and inter-rater reliability of the 50-foot Timed
Walk (50FTW) and 30CST in patients awaiting total hip or total knee replacement.
Eighty-two subjects who were participating in a 6-week exercise program were recruited.
Measurements were collected at baseline, 7 weeks and 15 weeks. During each testing
occasion, four trials of the 50FWT and two trials of the 30CST were completed, as the
30CST may be more likely to exacerbate pain. The study also explored if a practice
effect may be responsible for improved performance. ICC (1,1) was calculated for each
testing occasion and resulted in ICCs for the 50FTW ranging from 0.93 (95%CI 0.91 to
0.96) to 0.97 (95%CI 0.96 to 0.98). The SEM was 1.32 seconds and the MDC90% was
calculated to be 3.08 seconds. These were calculated from the baseline assessment
scores. It was noted by comparing mean scores that the first trial of the 50FWT was
slower than subsequent trials. Results were similar for the 30CST with results ranging
from 0.95 (95%CI 0.93 to 0.97) to 0.98 (95%CI 0.97 to 0.99). For baseline scores the
SEM was 0.70 stands and the MDC90% was 1.64 stands. As the SEM and MDC90%
were calculated from baseline scores, we are unaware if these are similar when repeated
after an intervention has taken place. The authors concluded that the 50FWT and the
30CST could be reliable measures in those awaiting joint replacement. They did note
that a practice trial should be administered when first introducing the test as significant
differences were noted between trial one and trial two. These stabilized for the remainder
of the 50FWT trials, but we are unsure if the same would hold true for the 30CST as only
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two trials were completed due to concerns of increasing pain. The protocols described in
this study were used in the study completed for this thesis.
Fransen et al.,65 examined 41 patients with knee osteoarthritis. Each patient performed a
walk test over a course of 8 metres. Five trials were completed at a self-selected pace
that individuals considered normal, followed by five trials at a self-selected pace that
individuals considered fast. A rest period of 45-60 seconds was provided between each
trial. A total of three test occasions were completed at one week intervals. Results
showed that the ICC (2,1) were consistently high ranging from 0.90 to 0.98 with the
lower boundaries of the 95%CI ranging from 0.84 to 0.96. The authors noted superior
test-retest reliability in the fast-self-selected walking speed as compared to the normal
self-selected speed. The SEM 90%CI was calculated as +/-0.12 m/s. Similar to other
studies they noted that there was a learning curve and a practice trial allows for
familiarization where stability between the second and third trials was achieved.
Kennedy et al.,55 examined the reliability and sensitivity to change of the 6MWT, TUG,
Stair Climb Test and a Fast Self-Paced Walk Test (SPWT) in patients with hip and knee
osteoarthritis who went on to have a total hip or total knee arthroplasty. Test-retest
reliability (ICC (2,1)) was assessed in 21 patients at three time points prior to surgery.
Subjects were required to walk two lengths of a 20 metre course (excluding turns) and
given the instruction “walk as quickly as you can without overexerting yourself”. The
median time between the first and second test occasions was 91 days and between the
first and third test occasions was 178 days. The authors felt that time between testing
sessions was acceptable to establish test-retest reliability as previous literature had
suggested that the amount of functional change while someone was on the waitlist is
minimal. The estimated reliability was calculated as ICC = 0.91 (95%CI 0.81 to 0.97),
SEM 1.73 (95%CI 1.39 to 2.29) confidence in score 90% = +/- 2.86sec and MDC90% =
4.04 seconds. In conclusion, the authors felt that the measure met the requisite standards
for acceptable reliability for making decisions at the individual patient levels. It must be
noted that no test-retest reliability analysis was completed following surgery and the
sample size used for the analysis was quite small. Responsiveness of the measure will be
discussed in a future section.
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Perera et al.,66 examined 692 participants enrolled in three different studies. The three
data sets were used and analyzed. Gait speed was calculated in meters/second and
distance covered in the different studies ranged from 10 feet to 10 metres. Test-retest
reliability estimates were calculated from a subsample of subjects from the studies and
used to calculate the SEM. ICC values were not reported. SEM results varied from
0.04m/s for a 10 metre distance to 0.10 m/s for a distance of 10 feet. Meaningful change
was then estimated using both an anchor-based and distribution-based method. The
overall recommendations outlined a change of 0.05 m/s and 0.10 m/s were required to
meet a small and substantial meaningful change with a 10 m gait speed test.
Barthuly et al.,67 highlighted that restoration of walking is a primary concern for those
undergoing short-term rehabilitation. Relevance to community ambulation, incident
health events and mortality has led many to recommend gait speed as a clinical vital sign.
136 patients admitted for short-term rehabilitation participated in a prospective
observational study. Participants were tested on admission, the following day and prior
to discharge (mean of 15.1 days). Gait speed was assessed over a 5.2 m course with time
beginning after a 1 m distance allotted for acceleration. ICC was estimated at 0.932
(95%CI 0.906 to 0.951). The SEM was calculated as 0.05 m/s and the associated
MDC95% was 0.13 m/s. The authors concluded that results were consistent with
previous studies.
Davey et al.,68 looked to estimate the test-retest reliability of a number of functional and
self-report measures in 21 elderly subjects with hip and knee osteoarthritis. The
participants were part of a larger RCT to determine the cost-effectiveness of water
therapy for those with OA. The walking test required subjects to ambulate over a
distance of 8 feet with an additional 2 feet at either end. Individuals were asked to walk
“at their own pace”. Two trials were allowed with the faster of the two being noted. The
measures were repeated on two occasions less than a week apart. The study looked to
estimate test-retest reliability to determine the degree to which the same result can be
obtained with repeat measurements. The SEM was estimated to provide information as
to how useful a measure may be for monitoring change in performance and the variation
that might be expected for a measure. Test-retest correlations were estimated using
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Pearson’s correlation co-efficient and reported as r = 0.90. SEM was reported as 0.12
seconds (95%CI -0.07 to 0.29). MDC90% was not reported. One concern is using
Pearson coefficient rather than an Interclass Correlation Coefficient to estimate
reliability. As mentioned previously, Pearson does not take differences between score
into account, only how they vary to each other. This may lead to an overestimation of
agreement.
Dobson et al.,61 set out to evaluate the reliability and measurement error of the OARSI
recommended performance-based tests of physical function in 51 people with hip and
knee osteoarthritis. The performance-based measures included the 40FPWT, 10FPWT
and 30CST. Relative reliability was calculated using ICCs and absolute reliability was
estimated using SEM and MDC. Participants completed the measures on two test
occasions, one-week apart. Within-rater reliability was calculated using an ICC (2,1) and
between-rater using an ICC (1,1).
For the 40FPWT the ICC (1,1) for the 40FPWT was 0.96 (95%CI 0.93 to 0.98) and SEM
0.06 m/s (95%CI 0.05 to 0.08). The ICC (2,1) was estimated as 0.92 (95%CI 0.82 to
0.96) and SEM 0.07 m/s (95%CI 0.06 to 0.09). MDC90% was estimated as 0.19 m/s.
Results for the 10FPWT ICC (1,1) was 0.91 (95%CI 0.83 to 0.95) and ICC (2,1) was 0.88
(95%CI 0.80 to 0.93). SEM was 0.10 m/s (95%CI 0.09 to 0.13). MDC90% was
estimated as 0.28 m/s. The 30CST measured in number of stands was estimated as 0.86
(95%CI 0.77 to 0.92) with an SEM of 1.0 (95%CI 0.8 to 1.3) and within-rater as 0.85
(95%CI 0.67 to 0.93) with an SEM of 0.9 (95%CI 0.7 to 1.1). MDC90% was estimated
at 2.0 stands.
The authors concluded that sufficiently small measurement error associated with the tests
indicate these tests are appropriate for measuring change in those with hip and knee OA.
The results also indicate that the 10FPWT is an acceptable alternative to the 40FPWT.
Marks,69 evaluated the reliability of the 13 m walk test in 15 females with knee OA.
Subjects completed two trials of the test with a 2 minute rest period in between. The
same protocol was carried out 1 week later with no intervention in between. Results
concluded ICCs for the tests conducted within and across sessions were 0.98, 0.99, 0.88
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and 0.80, respectively. 95%CI was not reported. The average SEM across sessions was
1.06 seconds. MDC 90% was not reported. In contrast to other studies, Marks reported
that there were no systematic learning curve or fatigue effects with repeated testing. The
author did admit that a larger sample size would be ideal in further studies.
Jones et al.,70 evaluated the 30CST as a measure of lower body strength in communityresiding older adults. 76 community-dwelling older adults completed two 30CST and
two maximum leg-press tests; these were repeated 2 to 5 days later. The authors were
interested in the 30CST as an alternative to other sit to stand tests that required an
individual to complete a minimum amount of sit to stands. It was observed that a number
of older adults could not complete the minimum number of stands required for the test,
which resulted in a floor effect. A floor effect results when a subject cannot reach the
minimum requirements of a test.71,72 Test-retest ICC for the 30CST was estimated at 0.89
(95%CI 0.79-0.93). The authors noted that all participants were able to complete the
30CST with scores ranging from 2 to a maximum of 21. They concluded that the 30CST
had the capability of assessing a wider range of ability levels and did not demonstrate the
same floor effect that other tests that required a minimum number of stands had
previously in the literature.
Wright et al.,73 assessed patients with a diagnosis of hip or knee OA, who were part of a
larger trial, in an effort to estimate reliability of the 40FPWT, TUG, 30CST and 20-cm
Step Test. Two different raters tested participants, one week apart, prior to any
intervention. ICC (2,1) was calculated for the 40FPWT as 0.95 (95%CI 0.90 to 0.98)
with an SEM of 1.00 m/s. The ICC for the 30CST was estimated as 0.81 (95%CI 0.63 to
0.91) with a SEM of 1.27 stands. The authors indicated that 33 patients were required for
the reliability assessment. Unfortunately, this was not achieved and may have impacted
the significance of the results.
Tolk et al.,74 conducted a prospective cohort study to investigate the reliability, validity
and responsiveness of the OARSI core set of performance-based outcome measures that
include the 30CST, 40FPWT and Stair Climb Test. Participants included 85 patients
with knee OA who were awaiting TKA. Measures were collected pre-operatively and 12
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months following surgery. Test-retest calculations were obtained pre-operatively with a
30-minute rest period between testing sessions. Appropriate test-retest reliability was
found for all three tests. For the 30 CST an estimated ICC of 0.90 (95%CI 0.68 to 0.96),
SEM 0.85 stands and smallest detectable change (SDC = 1.96 x √2 x SEM) of 2.4 stands
was reported. The 40FPWT yielded a similar ICC of 0.93 (95%CI 0.85 to 0.96), SEM
0.10 m/s and SDC of 0.27 m/s.
Reliability of Performance-Based Outcome Measures in rehabilitation following TKA
The relative and absolute reliability of sit to stand and walk tests has been established for
a number of different types of tests and suggests good to excellent reliability. When
exploring reliability of these performance-based outcome measures, many studies have
included patients with hip and knee OA who may or may not be awaiting total joint
arthroplasty. Those studies that included patients who underwent TKA calculated
reliability in testing sessions that occurred prior to surgery. To our knowledge, there are
no reports to date of relative or absolute reliability estimates calculated during
rehabilitation following TKA. As well, the MDC90% that has been reported has been at
a single time point prior to surgery. In order to accurately estimate the relative and
absolute reliability, along with the MDC90% at various time points in rehabilitation
following TKA these performance-based outcome measures need to be examined in the
desired population at the appropriate time points following surgery.
Validity of Sit to Stand/Walk Test
Using a head-to-head comparison design, Gill et al.,64 assessed and compared the validity
of six physical function measures in 82 people awaiting TKA or THA. The measures
examined included the WOMAC physical function (WOMACpf) scale, SF-36 Physical
Component Summary Scale, Patient Specific Functional Scale, 30CST and 50-foot timed
walk. Validity was explored by assessing convergent validity, discriminative validity,
known-groups validity and responsiveness. Spearman’s rho correlation coefficients were
calculated when investigating convergent and discriminative validity. The 30CST had
moderately high correlations with the 50-foot walk test (ρ = 0.64) and WOMACpf (ρ =
0.62). The correlation between the 50-foot walk test and WOMACpf was moderately
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correlated (ρ = 0.42). All three of the mentioned tests had evidence of known-groups
validity and were able to distinguish between subjects who were using a gait aid and
those who were not. Standardized response means (SRM) of 0.2, 0.5 and 0.8 have been
interpreted to represent small, moderate and large responsiveness to change.75 The
30CST had large responsiveness (0.84, 95%CI 0.61 to 1.07) while the 50-foot walk test
(0.45, 95%CI 0.22 to 0.68) and WOMACpf (0.70, 95%CI 0.47 to 0.93) had a more
moderate response.
Jones et al.,70 conducted a study to examine the validity of the 30CST as a measure of
lower body strength in adults over the age of 60. A moderately high correlation was
found between the 30CST and weight-adjusted leg press (r = 0.77, 95%CI 0.64 to 0.85).
It was also observed that the 30CST could discriminate between age groups and levels of
physical activity.
Wright et al.,73 compared three methodological approaches to establishing the major
clinically important improvement (MCII) of four tests, including the 30CST and
40SPWT. Three anchor-based approaches were used in patients with hip OA. An
anchor-based approach compares changes in the outcome measures’ score to an external
standard; often used is the Global Rating of Change (GRC). The authors selected a GRC
score of greater than +5 to represent an important change. Patients who indicated a major
improvement had statistically significant greater improvements in the 40 SPWT and
30CST. When comparing the three methodological approaches, the MCII for the 30CST
varied from 2.0 to 2.6 stands and the 40SPWT from 0.2 to 0.3 m/s.
French et al.,76 conducted a study to compare the responsiveness of two self-report
measures and three performance-based measures in patients with knee OA after
physiotherapy. Both the WOMAC and timed-stand-test were included in their
investigation. The timed-stand-test change score was significantly different (p<0.002)
indicating the result of the outcome was different following intervention. An SRM of
0.39 and ES of 0.36 demonstrated a small effect size based on Cohen’s criteria.
Marks,69 conducted an observational study to investigate the validity of the 13-m walk
test in 15 patients with knee OA. A positive correlation (r = 0.66) was found between the
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walk test and the functional handicap scores on the Lequesne Index of Severity for Knee
OA. No relationship was identified between the walk test and age, weight or height.
In 2003, Stratford et al.,77 conducted an observational study of 93 patients awaiting total
hip or knee arthroplasty. The authors explored the correlation between the Lower
Extremity Functional Scale (LEFS), the self-paced walk test (SPW) (2 lengths of a 20m
indoor course), TUG and stair test. A significant correlation was reported between the
LEFS and self-paced walk test (r = 0.44, 95%CI 0.26 to 0.59). To further investigate the
content validity of the timed tests, the LEFS walk items were correlated with the SPW.
This yielded similar results r = 0.47 (95%CI 0.29 to 0.61). Performance-based measure
outcomes are reported in time and do not take into account pain or perceived exertion.
Following the completion of the performance-based measure, participants were asked to
rate their pain when performing the test and their rate of perceived exertion. When the
time, pain and exertion scores were pooled for the SPW test, the correlation with the
LEFS was significantly greater, r = 0.59 (95%CI 0.44 to 0.71). The authors concluded
that adding pain and exertion domains would heighten the content validity of the
performance-based test.
Kennedy et al.,55 conducted an observational evaluating the sensitivity to change of four
performance-based measures following total hip and knee arthroplasty. Two time points
following surgery were to be explored to assess the ability of the measures to detect
change, both deterioration and improvement. Participants were evaluated preoperatively, within 15 days post-operatively and a minimum of 20 days occurred between
the second and third testing session. SRM for the self-paced walk test was estimated at 0.89 (95%CI -1.42 to -0.68) between the pre-operative and first post-operative testing
session. The negative score was associated with deterioration in function, which would
be expected so soon after surgery. The SRM during the post-operative phase was
reported as 0.79 (95%CI 0.66 to 1.45).
Barthuly et al.,67 conducted a prospective observational study involving patients admitted
to short-term rehabilitation following an acute-care hospitalization. The majority of
subjects had undergone total knee arthroplasty. Gait speed was measured at a
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comfortable speed over 5.2 m and measured at baseline, 2 days later and just prior to
discharge. The mean time between admission and discharge was 15.1 days. ES
estimation for gait speed was 1.11 and SRM was 1.25. Minimal clinically important
difference (MCID) was also explored and was reported between 0.10 m/s and 0.18 m/s
depending on the anchor used to establish significant change.
Borjesson et al.,78 set out to identify the most discriminative walking speed to be used
when evaluating patients with knee osteoarthritis following unicompartmental knee
arthroplasty or high tibial osteotomy. 54 individuals walked a 5 m distance, with 3 m of
walkway at each end to allow for acceleration and deceleration. The distance was
completed with walks at slow, normal and fast speeds. The first test occasion occurred
prior to surgery and the second, one-year following surgery. During each testing session,
two trials were completed with the second trial used for the calculation. Responsiveness
was calculated as ES, SRM and relative efficiency. Relative efficiency was estimated
with t-statisticfastpace/t-statisticnormalpace). All subjects with unilateral knee OA had a
significant ( p<0.001) improvement in their walking speed from pre-surgery to postsurgery. ES ranged from 0.34 to 0.58 and SRM varied from 0.49 to 0.71. For both ES
and SRM the slow walking had the highest values.
Tolk et al., examined the construct validity and responsiveness of the OARSI core set of
performance-based outcome measures.74 Creating predefined hypotheses assessed both
properties. Measures would be assumed valid and responsive if at least 75% of the
hypotheses were confirmed. Based on this evaluation procedure it was determined that
none of the tests met the construct validity criteria and only the 40FPWT was considered
to be responsive. When reviewing each hypothesis, it is observed that correlation
between the performance-based and self-report measures varied between -0.25 and 0.35.
Change scores and analysis of responsiveness between the anchor-question using a GRC
and the change score on the self-report-measure of function ranged between -0.22 and
0.43. The authors concluded that the performance-based measures were not valid or
responsive and therefore do not justify their use in clinical practice. A statement like this
needs careful consideration, as it was the predefined hypotheses that determined the
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validity and responsiveness. Had other parameters been used the results and conclusion
may have differed greatly.
Validity of Performance-Based Outcome Measures in rehabilitation following TKA
It appears that there is at best a moderate association between self-report and
performance-based measures, including sit to stand and walk tests. The two can be
considered complementary, but do not measure the same construct. Stratford et al54
concluded that performance-based measures may be more sensitive to change than selfreport measures. Based on the above literature review, it also appears that inquiry into
the psychometric properties of sit to stand and walk tests has not been evaluated
previously in post-operative arthroplasty populations (i.e., TKA and THA). Furthermore,
to our knowledge, previous studies have not investigated the longitudinal and concurrent
validity of the 30CST and 10MWT during rehabilitation following TKA. As previously
mentioned, it has been recommended that these outcome measures should be used in
clinical practice7,9,11,12,62, and thus requires normative data to ensure optimization of
clinical outcomes. Normative data has been established for the 30CST and 10MWT in
community dwelling adult populations,70,79,80 and could provide a benchmark for
recovery from arthroplasty procedures. Establishing these measurement properties in this
population is essential to help determine functional change and may assist in identifying
superior treatment pathways.
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Chapter 3
Methods
Study Design
The study design was prospective and observational with repeated measures. Patients
performed the 30CST and 10MWT and completed the WOMAC and the Global Rating
of Change (GRC) questionnaires on three occasions. The initial testing occasion was
during their initial assessment at the LHSC-UH Physiotherapy Clinic (approximately four
weeks following surgery). The second and third occasions were at six weeks and twelve
weeks following surgery respectively. This was the usual standard of care for all TKA
patients referred to our facility. From these time points we were able to evaluate
longitudinal validity. In order to evaluate test-retest reliability, a subgroup of patients
completed one or two additional testing session and repeated the two PBOMs 24 to 48
hours following their six-week and twelve-week postoperative testing (Figure 1).
Participants
We recruited patients between the ages of 45 and 88 years. All patients had undergone a
unilateral primary total knee arthroplasty (TKA) resulting from end stage osteoarthritis
(OA) as determined by the treating surgeon at London Health Sciences Centre –
University Hospital (LHSC-UH). All patients were recruited from the Physiotherapy
Clinic at LHSC-UH.
Patients were excluded if they had undergone a revision TKA, bilateral TKA or
unicompartmental TKA. Patients with rheumatoid arthritis, diagnosed neurological
movement disorder or concurrent musculoskeletal condition (e.g. back, hip or ankle
injury) leaving them unable to complete performance-based outcome measures (PBOM),
were also excluded. Patients were required to understand, read and write in English to
complete study questionnaires. The institution’s ethics board review board approved the
study and all participants provided informed consent prior to participation. The study
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Figure 1 - Schematic Diagram of Study Design
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Letter of Information and Ethics Approval Notice are provided in Appendices A and G
respectively.
Sample size was based on our primary responsiveness analysis which calculated the
correlation between the GRC and the two PBOMs as this required the largest sample size.
Considering an alpha of  = 0.05 and an expected Pearson’s r of 0.6 with a 95% CI width
of 0.3, we required a minimum sample size of 74 patients with complete data.81 In order
to account for a potential loss to follow-up rate of 20% we planned to recruit 89 patients.
We ensured that at least 30 patients participated in the reliability testing, providing the
ability to estimate an ICC of at least 0.85 with 95% CI width of 0.2.82
Testing Procedures
The testing procedures were identical on each test session. LHSC-UH Physiotherapy
Clinic clinical staff administered testing. All staff received training on test administration
and utilized identical protocols and equipment. The primary study assessor assessed
them for competency.
On the initial test occasion, the investigator collected demographic data from the patients
and entered it into the data collection form (Appendix B). On the three standard test
occasions, patients completed the Western Ontario and McMaster Universities
Osteoarthritis Index (Appendix D), a condition-specific self-report questionnaire
designed for patients with hip and knee OA. The questionnaire consists of 24 questions
across three categories: pain, stiffness and physical function. Individuals are asked to
rate their level of difficulty on a five-point scale with 0 = None, and 4 = Extremely. The
total score is out of 96, with higher scores indicating greater difficulty. The WOMAC’s
reliability and validity are well established in hip and knee OA.83 Subsequent to the
initial test occasion, patients also completed two GRC questionnaires. The GRC scale is
used to quantify a patient’s improvement or deterioration over time.84 Patients were asked
two questions, “With respect to your joint replacement surgery, how would you rate your
pain (1) or function (2) now, compared to when you first started physiotherapy here at
University Hospital?” The GRC utilized in this study was a 15-point adjectival scale
ranging from -7 (a very great deal worse) to +7 (a very great deal better). A score of 0
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indicates the same, or no change. Other responses were scored as follows: a tiny bit
better/worse, almost the same = 1; a little bit better/worse = 2; somewhat better/worse =
3, moderately better/worse = 4; a good deal better/worse = 5; a great deal better/worse =
6; a very great deal better/worse = 7 (Appendices E and F). The test administrator also
measured active knee range of motion and recorded if a gait aid was required during each
testing occasion.
The two PBOM were administered according to adapted protocols outlined by Gill et al.63
and Tilson et al.85 The tests included the 10 Metre Walk Test (10MWT) and the 30 Chair
Stand Test (30CST). Each patient completed the WOMAC and GRC prior to the
PBOMs. The two PBOMs were completed in the same order, as listed above, at each test
occasion.
The 10MWT required the subject to walk as fast as they can, safely, over a total distance
of 14 metres. The walking course was set up in a hallway and included a 2 m distance at
the beginning and end to allow for warm up and slow down. The 10 m in between was
used for the speed measurement. Subjects were allowed to use their appropriate gait aid,
which the assessor noted. Two trials were conducted, with a short rest period between as
required (Appendix C).
The 30CST was performed following the 10MWT. A chair with a 17-inch seat height
and no armrests was placed against the wall. Patients were instructed to stand fully up
and fully down without using their hands and were given 30 seconds to complete as many
repetitions as possible. Each subject was allowed one trial sit to stand prior to the test
beginning (Appendix C). The same stopwatch was used for both tests and during all test
occasions.

Data Analysis
All statistics were calculated using IBM SPSS Statistics version 25. Descriptive
statistics, including mean and standard deviation of the sample were calculated. On each
test occasion, the 10MWT scores were recorded in absolute time (in seconds) and were
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calculated as the mean of the two-recorded trials. The 30CST scores were recorded as an
absolute number.
Objective 1 – Test-retest Reliability
10MWT and 30CST scores from occasions: 2 and 3, and, 4 and 5 were compared using a
series of paired t-tests.

Test-retest reliability was assessed using values obtained from test occasions 2 and 3 (6
weeks postoperatively) and test occasions 4 and 5 (12 weeks postoperatively). Relative
reliability was estimated using Intraclass Correlation Coefficients (ICC) with a two-way
random model for consistency. Absolute reliability was estimated using the Standard
Error of Measurement (SEM). SEM was calculated as the standard deviation (SD)√(1ICC). The SEM was also used to calculate an estimate of the Minimal Detectable
Change at 90% confidence level (MDC90), by multiplying the SEM by √2 and the z
value for 90% confidence (1.64). Lastly, we created Bland and Altman plots for the two
performance-based outcome measures at both 6 and 12 weeks postoperatively (Figures 36).
Objective 2 – Longitudinal Validity
Longitudinal validity and sensitivity to change were evaluated using the change scores
between test occasions: 1 and 2 (initial to 6 weeks postoperative), 1 and 4 (initial to 12
weeks postoperative) and 2 and 4 (6 weeks postoperative to 12 weeks postoperative).

Pearson correlation coefficients (r) were used to determine the association between the
change in each performance-based measure, the GRC pain and function, and change in
WOMAC physical function subscale.

The ability to detect change was expressed by calculating both the standardized response
mean (SRM) and effect size (ES). The SRM was calculated by dividing the mean of the
change scores by the standard deviation of the change scores. The ES was calculated by
dividing the mean of the change scores by the standard deviation of the baseline score.
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Specifically, when calculating the ES for initial to 6 weeks post-op and initial to 12
weeks post-op, the SD from the initial score was used. When calculating the ES from 612 weeks post op, the SD of the score at 6-weeks was used. These values assist in
evaluating how well a measure can distinguish “signal” from “noise”.

Objective 3 – Concurrent Validity
In order to explore concurrent validity of the 10MWT, 30CST and WOMAC physical
function subscale, Pearson’s r was also calculated.

Finally, known-groups validity was investigated by comparing scores on each of the
performance-based measures for individuals who walked with a gait aid versus those who
walked without a gait aid. A statically significant difference using an independent t-test
identifies that known-groups validity is achieved.
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Chapter 4
Results
Eighty-five patients we approached as potential participants. Those who did not enter the
study had undergone revision surgery (1) or were unwilling to participate (1). Eightythree participants were entered into the study (Figure 2.). Complete data were collected
on 80 patients.
During the study two patients did not attend their twelve-week testing sessions. Multiple
attempts were made to contact the patients to schedule an appointment however we were
unsuccessful. One subject was excluded in the sensitivity to change portion of the study
as she had a respiratory infection and could not complete the 30CST. The final sample
consisted of eighty-one patients who attended testing session at all three time points
(initial visit, six weeks and twelve weeks postoperative). Forty-five patients completed a
second testing session 24-48 hours following the six-week testing and thirty-seven
patients completed a second testing session 24 to 48 hours following the twelve-week
testing session to evaluate test-retest reliability of the two PBOMs.
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Figure 2 - Enrollment Flow Chart
Enrollment

Assessed for eligibility (n= 85)

Excluded (n=2)
¨ Not meeting inclusion criteria (n=1)
¨ Declined to participate (n=1)

Enrolled in study (n=83)

Follow-Up at 6 weeks
Completed second testing session 24-48 hours
later (n=45)

Completed testing session (n=83)
Lost to follow-up (n=0)

Follow-Up at 12 weeks
Completed testing session (n=81)
¨ Lost to follow-up: missed appointments (n=2)

Completed second testing session 24-48 hours
later (n=37)

Figure 2. Enrollment flow chart
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A summary of patient characteristics is outlined below (Table 1) including; age, height,
weight, BMI, length of postoperative stay in hospital, number of comorbidities, number
of home care visits, days from surgery to initial testing and use of gait aid at during initial
testing session.
Table 1. Patient Characteristics
Female Subjects Male Subjects Total
Sample size (n)

52

31

83

Age (y)

67.6 ± 8.8

69.5 ± 8.5

68.3 ±8.7

Height (m)

1.62 ± 0.07

1.75 ± 0.08

1.67 ± 0.10

Weight (kg)

89.8 ± 19.9

96.4 ± 16.0

92.3 ± 18.7

Body mass index

34.01 ± 6.45

31.38 ± 4.20

33.02 ± 5.83

Length of stay (days)

2.48 ± 1.04

2.10 ± 0.91

2.34 ± 1.00

Co-morbidities (n)

2.50 ± 1.50

1.68 ± 1.14

2.19 ± 1.43

Home care visits (n)

3.63 ± 1.1

3.65 ± 0.8

3.64 ± 1.0

Days from surgery (days)

29.87 ± 5.77

28.45 ± 5.12

29.24 ± 5.55

21

59

Gait aid at initial testing (n) 38

Mean ± Standard Deviation
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A summary of statistics for the 30CST scores, 10MWT scores, knee flexion range of
motion in degrees, WOMAC physical function (WOMACpf) scores and Global Rating of
Change function (GRCf) on all test occasion are below in Table 2.
Table 2. Mean ± Standard Deviation for All Subjects for 30CST, 10MWT, Knee Flexion,
WOMACpf and GRCf on Five Separate Test Occasions

Test

Initial Testing

6-wk Postop

6-wk re-test

12-wk Postop

12-wk re-test

N

83

83

45

81

37

30CST (n)

4.2 ± 3.9

8.7 ± 3.9

9.2 ± 3.5

12.2 ± 3.76

12.8 ± 2.9

10MWT (s)

14.88 ± 9.32

10.45 ± 2.95

9.97 ± 2.2

8.30 ± 1.96

8.12 ± 1.61

Knee

100.6 ± 15.2

112.6 ± 11.5

-

120.8 ± 8.32

-

WOMACpf

33.4 ± 13.6

24.66 ± 12.4

-

16.28 ±12.1

-

GRCf

-

4.4 ± 2.1

-

5.77 ± 1.1

-

Flexion (°)

For all tests completed, paired t-tests determined that all the scores on each test occasion
were significantly different.
For the 30CST there was a significant difference in all scores between all test occasions
(p < 0.001), this included a significant difference between test occasions 2 and 3, and 4
and 5, which were collected to establish test-retest reliability.
The results of the 10MWT were similar in that scores between all test occasions were
significantly different. The difference between the scores obtained on the first and
second test occasion was significant with p < 0.01. Between score differences on test
occasion 1 and 3 were p < 0.005. For the remainder of the scores, the comparison
between test occasions 2-3, 3-4 and 4-5 were significantly different (p < 0.001).
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Objective 1 – Test-retest Reliability
Reliability statistics for the 30CST and 10MWT are outline in Tables 3 and 4. These
values were calculated at both 6 weeks and 12 weeks post op.
Table 3. Reliability for All Subjects (n=45) Between Test Occasions Two and Three (6
Weeks Postoperatively): Mean Difference, Interclass Correlation Coefficients (ICC),
Standard Error of Measurement (SEM) Minimal Detectable Change Estimated Using the
z Value for 90% Confidence (1.64)
Test

Mean Difference (95%CI)

ICC (95%CI)

SEM (95%CI)

MDC90

30CST

-0.91 (-1.20 to -0.62)

0.96 (0.93 to 0.98)

±0.67 (0.57 to 0.87)

±1.56

0.82 (0.70 to 0.90)

±1.05 (0.88 to 1.34)

±2.43

10MWT 1.04 (0.50 to 1.49)

Table 4. Reliability for All Subjects (n=37) Between Test Occasions Four and Five (12
Weeks Postoperatively): Mean Difference, Intraclass Correlation Coefficients (ICC),
Standard Error of Measurement (SEM) Minimal Detectable Change Estimated Using the
z Value for 90% Confidence (1.64)
Test

Mean Difference (95%CI)

ICC (95%CI)

SEM (95%CI)

30CST

-0.97 (-1.35 to -0.59)

0.93 (0.86 to 0.96)

±0.79 (0.66 to 1.05) ±1.84

0.89 (0.80 to 0.94)

±0.57 (0.47 to 0.75) ±1.32

10MWT 0.53 (0.26 to 0.80)

MDC90

For the 30CST at 6 weeks postoperatively the ICC (0.96, 95%CI 0.93 to 0.98) and SEM
(±0.67, 95%CI 0.57 to 0.87) indicated acceptable reliability. The same is true for 12
weeks postoperatively where the ICC (0.93, 95%CI 0.86 to 0.96) and SEM (±0.79,
95%CI 0.66 to 1.05) also confirmed adequate reliability. The minimal detectable change,
at the 90% confidence interval, was 1.56 stands and 1.84 stands at 6 and 12 weeks
following surgery respectively.
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For the 10MWT at 6 weeks postoperatively the ICC (0.82, 95%CI 0.70 to 0.90) and SEM
(±1.05, 95%CI 0.88 to 1.34) were also satisfactory. The same can be said at 12 weeks
postoperatively with the ICC (0.89, 95%CI 0.80 to 0.94) and SEM (±0.57, 95%CI 0.47 to
0.75). The minimal detectable change, at the 90% confidence interval, was 2.43 seconds
and 1.32 seconds at 6 and 12 weeks following surgery respectively.
Figure 3 – Bland-Altman plot for test-retest agreement of the 10MWT at 6 weeks
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Figure 4 – Bland-Altman plot for test-retest agreement of the 30SCST at 6 weeks

Figure 5 – Bland-Altman plot for test-retest agreement of the 10MWT at 12 weeks
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Figure 6 – Bland-Altman plot for test-retest agreement of the 30CST at 12 weeks

Objective 2 – Longitudinal Validity
When comparing the 30CST and 10MWT scores from initial to 6 weeks following
surgery to 12 weeks following surgery, there was an improvement in each performancebased measure as the time from surgery increased. The same was observed with the
WOMACpf scores.
Change scores, SRMs and ES for the 30CST, 10MWT and WOMACpf from initial visit
to 6 weeks postoperative and initial visit to12 weeks postoperative are summarized in
Table 5-7. For each time interval, the 30CST had the greatest SRM followed by the
WOMACpf than the 10MWT. For the 30CST, from initial to 6 weeks postoperative, the
SRM (1.94) and ES (1.16) indicated that the performance-based outcome measures are
sensitive to clinical change. The results were similar from initial to 12 weeks
postoperative with an SRM 1.94 and ES 2.07.
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Table 5. Initial to 6 Weeks Postoperative: Mean change scores (scores from trial 2 - trial
1) for 30CST and 10MWT and WOMACpf
.
Test
30CST
10MWT
WOMACpf

Mean change score (95% CI) SRM
4.55 (3.70 to 5.30)
4.42 (2.71 to 6.13)
8.69 (6.29 to 11.08)

1.30
0.56
0.79

ES
1.16
0.48
0.64

Table 6. 6 to 12 Weeks Postoperative: Mean change scores (scores from trial 4 - trial 2)
for 30CST and 10MWT and WOMACpf
Test
30CST
10MWT
WOMAC

Mean change score (95% CI) SRM
3.54 (2.85 to 4.22)
2.17 (1.71 to 2.62)
8.06 (5.88 to 10.25)

1.14
1.06
0.82

ES
0.90
0.74
0.65

Table 7. Initial to 12 Weeks Postoperative: Mean change scores (scores from trial 4 trial 1) for 30CST and 10MWT and WOMACpf
Test
30CST
10MWT
WOMACpf

Mean change score (95% CI) SRM
8.12 (7.20 to 9.05)
6.65 (4.74 to 8.58)
16.67 (14.14 to 19.19)

1.94
0.77
1.46

ES
2.07
0.71
1.23

Pearson correlation coefficients (r) were calculated to explore the association between the
change scores on the two performance-based outcome measures, change score of the
WOMACpf and the GRCf. Values were calculated for changes between initial testing
and 6 weeks postoperative and initial testing and 12 weeks postoperative. Correlations
between the two performance-based tests and self-report measures ranged from -0.16 to
0.34. The strongest association was between the 30CST and GRCf at both time frames.
Results are summarized in Tables 8-9 below.
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Table 8. Pearson r Values (95%CI) for Correlations Between the 30CST Change Scores,
10MWT Change Score, WOMACpf Change Score and GRC Function and Pain from
Initial Testing to 6 Weeks Postoperative

Test

Global Rating of
Change Function

Global Rating of
Change Pain

WOMACpf Change
Score

30CST
10MWT
WOMACpf

0.34 (0.13 to 0.52)
0.05 (-0.17 to 0.26)
-0.10 (-0.31 to 0.12)

0.28 (0.07 to 0.47)
0.03 (-0.19 to 0.24)
0.07 (-0.15 to 0.28)

0.22 (0 to 0.42)
0.22 (0 to 0.42)
-

Table 9. Pearson r Values (95%CI) for Correlations Between the 30CST Change Scores,
10MWT Change Score, WOMACpf Change Score and GRC Function and Pain from
Initial Testing to 12 Weeks Postoperative

Test

Global Rating of
Change Function

Global Rating of
Change Pain

WOMACpf Change
Score

30CST
10MWT
WOMACpf

0.25 (0.03 to 0.45)
-0.16(-0.37 to 0.06)
0.07 (-0.15 to 0.28)

0.23 (0.01 to 0.43)
-0.01(-0.23 to 0.21)
0.22 (0.002 to 0.42)

0.15 (-0.07 to 0.36)
0.11 (-0.11 to 0.32)
-

The GRCf responses were then grouped into 0 (0-1 no change), 1 (2-3 little change), 2 (45 moderate change) and 3 (6-7 large change) and presented using a stem and leaf plot
(Figures 3-6). On observation, we see that those who felt they had a greater improvement
in function also had a greater change in their performance on a functional test
demonstrating responsiveness. Association between the 10MWT and self-report
measures was not as strong.
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Figure 7 - Comparison of Grouped GRC and 30CST change score at 6 weeks

Figure 8 - Comparison of Grouped GRC and 10MWT change score at 6 weeks
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Figure 9 - Comparison of Grouped GRC and 30CST change score at 12 weeks

Figure 10 - Comparison of Grouped GRC and 10MWT change score at 12 weeks

43

Objective 3 – Concurrent Validity
Correlations were then examined between the 30CST, 10MWT and WOMACpf at each
of the three testing time points and summarized in Tables 10-12 below. Similar to the
association in change score, the correlations at one time point between the two
performance-based measures and the WOMACpf score ranged between -0.05 and -0.33
for the 30CST and 0.21 to 0.27 for the 10MWT. Association was greater between the
30CST and WOMACpf scores at initial testing and 12 weeks post op than the 10MWT
and WOMACpf score. The 10MWT had a greater association with the WOMACpf score
at six weeks postoperative. The association between the two performance-based outcome
measures increased the further out from surgery and ranged from -0.34 to -0.57.

Table 10. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and
WOMACpf at Initial Test Occasion
Test

WOMACpf

30CST

10MWT

30CST
10MWT
WOMACpf

-0.33 (-0.51 to -0.12)
0.22 (0.01 to 0.42)
-

-0.34 (-0.52 to -0.13)
-0.33 (-0.51 to -0.12)

-0.34 (-0.52 to -0.13)
0.22 (0 to 0.42)

Table 11. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and
WOMACpf at 6 Weeks Postoperative Test Occasion

Test

WOMACpf

30CST

10MWT

30CST
-0.05 (-0.26 to 0.17)
-0.47 (-0.62 to -0.28)
10MWT
0.27 (0.06 to 0.46) -0.47 (-0.62 to -0.28)
WOMACpf
-0.05 (-0.26 to 0.17)
0.27 (0.06 to 0.46)
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Table 12. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and
WOMACpf at 12 Weeks Postoperative Test Occasion

Test

WOMACpf

30CST

10MWT

30CST
-0.16 (-0.37 to 0.06)
-0.57 (-0.70 to -0.40)
10MWT
0.21 (-0.01 to 0.41) -0.57 (-0.70 to -0.40)
WOMACpf
-0.16 (-0.37 to 0.06) 0.21 (-0.01 to 0.41)

Known-groups validity was examined to help establish if the two performance-based
outcome measures could differentiate between those who were using a gait aid or not
while completing the functional test. At all three testing occasions the mean scores
between those with a gait aid and those without were all significantly different indicating
the functional tests could differentiate between the two groups (Table 13).
Table 13. Mean ± Standard Deviation of Performance-Based Outcome Measure Score by
Use of Gait Aid

Gait Aid (n)

No Gait Aid (n)

Initial

16.81 ± 10.40 (59)

10.12 ± 1.90 (24)

6 Week Post Op

12.50 ± 3.03 (32)

9.17 ± 2.05 (51)

12 Week Post Op

10.60 ± 1.71 (15)

7.75 ± 1.61 (66)

Initial

3.39 ± 3.41 (59)

6.04 ± 4.51 (24)

6 Week Post Op

7.00 ± 3.93 (32)

9.78 ± 3.60 (51)

12 Week Post Op

10.00 ± 4.00 (15)

12.69 ± 3.55 (66)

10MWT Score (s)

30CST Score (n)

45

Chapter 5
Discussion
This study evaluated the measurement properties of the 30CST and 10MWT in patients
during the first 12 weeks of postoperative rehabilitation following TKA. Through this
study we were able to determine that these performance-based outcome measures can be
used as standardized outcome measures in those following TKA. The test-retest
reliability of the two measures is adequate as the presented ICC values are well above the
accepted value of 0.7074. Estimates of measurement error and minimal detectable change
in these scores are also provided for both the 6 and 12 week intervals following surgery
which can assist clinicians in determining if a true change has occurred with respect to
their patient’s functional status. Not only can these measurements be considered reliable,
but they are also sensitive to change as indicated by the change in scores over time and
calculated standardized response mean and effect size. Correlations between the change
scores on the two performance-based outcome measures and self-report measures,
including the WOMACpf and GRCf show that those who felt they had a greater
improvement in function also had a greater change in their performance on a functional
test. When evaluating the correlation between the WOMACpf and the two performancebased measures at a single time point the association is low to moderate at best,
concluding that both self-report measures and performance- based measures are required
to capture the overall function of those following TKA.
The ICC’s reported in this study suggest not only adequate, but excellent relative
reliability and signify that the 30CST and 10MWT are suitable for differentiating
between patients during rehabilitation following TKA. For test-retest reliability the
current study’s findings are similar to those ICC values published in previous research.
ICCs for the 30CST ranged from 0.93 to 0.96 depending on the time of evaluation during
rehabilitation, either 6 weeks or 12 weeks postoperatively. Gill et al.,63 reported ICCs
from 0.95 to 0.98 for those with knee osteoarthritis awaiting TKA. The ICC’s reported in
the present study were higher than those reported by Dobson et al.,86 and Tolk et al.,74
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(0.85 to 0.90). Again, populations observed in these studies were those with
osteoarthritis who may or may not be awaiting arthroplasty surgery.
Relative reliability for the 10MWT was estimated from 0.82 to 0.89; this was established
by using the mean of the two trials during each testing session. Estimated values were
slightly lower than those reported in the literature. Previous research has examined a
variety of gait speed tests using different distances and protocols. Using the 50FWT and
a protocol that the current study was modeled after, Gill et al.,63 estimated ICCs ranging
from 0.93 to 0.97. The protocol used by Fransen et a.,l65 required each participant to
walk a course of 8 metres. ICCs were consistently high ranging from 0.90 to 0.98.
Each of these studies allowed for four to five trials of the walk test and noted a significant
difference in the first and second test trials which stabilized for the remainder of the trials
indicating a learning curve was probable and a practice trial should be allowed. In our
study a significant difference was found between all test occasions, including those used
to establish test-retest reliability. Perhaps allowing for a practice trial and using values
once scores had stabilized would have changed this. As well, our population was in the
initial stages of rehabilitation following TKA, not those with osteoarthritis awaiting a
TKA; this could also contribute to the difference in scores. We would assume that
patients would remain stable between testing sessions, but other confounding factors,
such as pain management and other activities completed that day may influence their test
score.
Similarly, published values for the SEM and MDC90, measuring absolute reliability have
been estimated using individuals with knee osteoarthritis. To our knowledge no studies
have explored these measurement properties in those during rehabilitation following
TKA. These values are reported in a measure’s scale points and allow a clinician to
estimate the reliability of the measurements they take. As patients following TKA may
improve differently depending on the stage of recovery they are in, it is important that
absolute reliability values be estimated at these different time points to accurately
interpret the results.
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Previous research has estimated the SEM for the 30CST to be from 0.70 to 1.27
stands61,63,73,74 and the MDC90 to be from 1.64 to 2.4 stands.61,63,73,74 At 6 weeks
postoperative our study reported the SEM for the 30CST to be 0.67 and at 12 weeks
postoperative the SEM was calculated to be 0.79. Based on the estimated error in the
30CST at 6 weeks postoperative (SEM x 1.96 = ±1.31), a clinician can be 95% confident
that a measured value of 8 stands could vary from 6.7 to 9.3 stands, simply due to
measurement error. At the 12 week postoperative mark (SEM x 1.96 = ±1.55) this same
score could vary from 6.5 to 9.6 stands. With the calculated MDC90, 90% of stable
patients would change less than 1.56 stands at 6 weeks and 1.84 stands at 12 weeks
following surgery.
Comparing this study’s findings for the 10MWT to the literature is somewhat more
difficult as measures of gait speed are often varied with respect to distance walked,
selected pace and reported scale values (seconds versus m/s). If we compare our results
to the protocol our study was modeled after, Gill et al.,63 report the SEM and MDC90 for
the 50FWT to be 1.32 seconds and 3.08 seconds respectively. The subjects in this study
were awaiting a total hip or knee replacement and participating in a six-week exercise
program prior to surgery. Values were estimated from baseline scores and not following
the intervention. We estimated the SEM to be 1.05 seconds at 6-weeks post op and 0.57
at 12 weeks postoperative. Based on an estimated error in the 10MWT at 6 weeks
postoperative (SEM x 1.96 = ±2.06), a clinician can be 95% confident that a measured
value of 10.56 seconds could vary from 8.50 to 12.62 seconds, due solely to measurement
error. At the 12 week mark (SEM x 1.96 = ±1.12) this same score could vary from 9.44
to 11.68 seconds. Furthermore, with a calculated of MDC90 of 2.43 seconds at 6 weeks
and 1.32 seconds at 12 weeks, 90% of stable patients would change by less than 2.43 or
1.32 seconds.
When comparing the results of the two tests we observed that the MDC90 for the
10MWT decreased over time whereas the opposite occurred for the 30CST. This may be
due to the greater variability in scores during the 10MWT observed during the earlier
stages of recovery due to use of a gait aid, effect of surgery on ambulation and other
contributing impairments to gait.
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Using established performance-based measures, which have adequate reliability is
essential; however, in clinical practice using a measure that is able to detect change in an
individual makes the measure’s use clinically relevant. Change scores, standardized
response means, and effect size were calculated to explore the sensitivity to change of the
30CST and 10MWT.
For the 10MWT effect size ranged between 0.48 to 0.74, which as described by Cohen
indicates a moderate to large effect.56 Standardized response mean values were calculated
from 0.56 to 1.06, which again can be considered moderate to high. The highest values
were obtained between measurements taken at the 6 week and 12 week mark indicating
that at different times the ability of the 10MWT to detect change is better. These findings
are similar to Borjesson et al.,78 who evaluated 54 individuals following
unicompartmental knee arthroplasty prior to surgery and at one year post-operatively. ES
ranged from 0.34 to 0.58 and SRM from 0.49 to 0.71. The ability to detect change was
best when a slow gait speed was used; this may help direct selection of a test when
considering fast-paced versus self-paced walk test.
A similar trend was found with the 30CST where ES and SRM ranged from 0.90 to 2.07
and 1.14 to 1.94 respectively. In the case of the 30CST the highest values obtained were
between measurements taken at initial testing and 12 weeks postoperative. Values for
both measures were lower in the period evaluating change between initial testing and 6
weeks postoperative, this may have been due to the little time that was allotted for change
to occur. The mean time in days between initial testing and 6-week testing was 14.77
days (SD ±6.1) with the number of days ranging from 5 to 35 days. The interquartile
range during this period was 7 days. The ability to detect change in a shorter period of
time would be more challenging than given a sufficient amount of time when we would
expect a change to occur.
Overall the 30CST was able to detect change better than the 10MWT between all time
points. Gill et al.,64 reported a similar trend with the 30CST demonstrating a large
responsiveness (0.84) compared to the moderate result (0.45) from the 50FPWT. This
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finding may help clinical decision-making when selecting an outcome measure to be used
in clinical practice. Not only is the 30CST easier to administer than the 10MWT, but its
superior ability to detect change may make it the test of choice if their time for collecting
measures is a factor.
Our validity results agree with previous reports that performance-based measures and
self-report measures are, at best, moderately correlated57 When exploring change scores
between the initial and 6-week testing, correlations between the change in the 30CST and
GRCf (r = 0.34) and WOMACpf (r = 0.22) indicated that the change in ability to sit to
stand is only fairly57 associated with perceived change in function. The correlation was
similar when change scores between initial and 12-week testing were examined; GRCf (r
= 0.25) and WOMACpf (r = 0.15).
Correlation between the 10MWT change score and GRCf (r = 0.05) and WOMACpf
change score (r = 0.22) at 6- weeks and GRCf (r = -0.16) and WOMACpf change score
(r = 0.11) were significantly less than the 30CST. The GRC is commonly used in
musculoskeletal research to identify and quantify a patient’s change over time; however
the GRC places a significant cognitive demand on the patient84, in our case to remember
what they were like when they first began physiotherapy at University Hospital. The
GRC scale used in this study was a 15 adjectival scale ranging from -7 (a very great deal
worse) to +7 (a very great deal better). To evaluate responsiveness, we grouped the
responses where those answering 0-1 indicated no change, 2-3 was a small amount of
change, 4-5 and moderate amount of change and 6-7 a large amount of change. The
results were then analyzed using a stem and leaf plot. From this we can visualize that
those who felt that they had a greater change in function also had a greater change score
on both the 30CST and 10MWT. The exception was with the 10MWT at 12 weeks
which could be associated with a potential ceiling effect.
Correlation at a single time point between the WOMACpf and 30CST ranged from –0.05
to -0.33. For the 10MWT values were fairly consistent over the three test occasions (r =
0.21 to 0.27). These findings are similar to Tolk et al.,74 yet compared to other studies
where the performance-based measures were correlated to self-report measures of
outcome64,69,77 the correlation is lower. One reason for this may be the difference in the
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population that our study was exploring the measurement properties in. Previous
literature tended to focus on those with osteoarthritis awaiting TKA where individuals
may have been more stable and homogeneous. Their perceived function and influence of
pain on perceived function would be very different than an individual who had just
undergone joint replacement surgery. Those studies that did include postoperative
patients evaluated them at time points outside of the first three months in rehabilitation.78
Establishing measurement properties in performance-based outcome measures is
important but it is only the first step. Encouraging utilization and assisting in interpreting
results to drive clinical decision-making is key to ensure translation of research into
practice. The potential clinical use is demonstrated in the following example:
Your patient is a 71-year-old male who underwent a right total knee arthroplasty 3
months ago. Six weeks ago, you evaluated his lower extremity strength and gait speed
using the 30CST and 10MWT. He was able to complete 9 stands in 30 seconds and the
mean score of his two trials on the 10MWT was 11.62 seconds. Following this you
implemented a progressive strengthening and walking program as he is planning on
returning to golf as soon as he is able to. Both you and the patient would like to evaluate
whether his strength and gait speed have changed over the six weeks of training. You
repeat the tests and today he is able to complete 15 stands and walk the 10-metre course
in 7.01 seconds.
•

What is the patient’s level of functional performance today?

The patient’ s 30CST is 15 stands, and you can be 95% confident that the true number of
stands lies between 13.5 and 16.5 stands. The patient’s 10MWT was completed in 7.01
seconds. You can be 95% confident that the true time is between 5.89 and 8.13 seconds
(see Table 4).
•

Has the patient’s functional performance truly improved over the past 6 weeks
of training?
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You know that 90% of stable patients would be expected to change by less than 1.84
stands and 1.32 seconds. As his 30CST improved by 6 stands and his 10MWT improved
by 4.61 seconds, you can be confident he has truly improved (see Table 4).
•

How would your assessment change if you wanted to use a performance-based
measure, but you have a busy day in clinic and cannot afford the time required
to administer both tests?

Overall the 30CST had the highest relative reliability and high sensitivity to change
(SRM = 1.14, ES = 0.90) between 6 and 12 weeks following surgery. The SRM and
MDC90 were only slightly higher for the 30CST than the 10MWT at the three-month
time point. Correlation to the GRCf and WOMACpf were low for both the 30CST and
10MWT, to note the correlation between the two performance-based measures at 3
months was considered moderate (-0.57). If a clinician had to pick one test to complete,
the 30CST may be the best option. This test also requires less time to complete and set
up is more amenable to limited space.

The objectives of this study were to examine the test retest reliability, longitudinal
validity and concurrent validity of the 30CST and 10MWT in patients following TKA.
This was accomplished, as the relative reliability and absolute reliability were determined
at two time points along with the SRM and ES. Further support for using these
performance-based measures was provided by revealing low to moderate correlations to
the GRCf and WOMACpf. The results suggest that using these two performance-based
measures is appropriate for those undergoing rehabilitation following total knee
arthroplasty.
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Limitations
The limitations of the study are as follows:
1) Patients were completing rehabilitation at the same centre; however, specific
interventions would be based on the patient’s individual situation and therapist
treatment philosophies. The variation in treatment may impact the level and pace
of improvement. For example, if patient A had been introduced to the sit test in
week 1 of treatment as an exercise vs. patient B who had not been introduced to
sit to as an exercise until week 6, the level of improvement would vary possibly
due to familiarity of the exercise.
2) There was some variation in the time when participants entered the study (i.e.
their first postoperative physical therapy assessment). The mean (SD) time from
surgery to first physical therapy visit was 29.24 (±5.55) days. The 6-week and
12-week assessments were based on the time from surgery.
Strengths
1) The study met the required sample size to explore both our validity and reliability
objectives. Only two subjects were lost to follow up.
2) The demographics of the sample suggest the results are generalizable to those
who have undergone a unilateral TKA and are appropriate for those who are
undergoing rehabilitation following TKA.
3) The study evaluated the measurement properties and established point estimates
and described the MDC90 for the two PBOM at both 6 weeks and 12 weeks
following TKA. This will allow clinicians to be confident in their interpretation
of results during testing sessions at different time points in recovery.
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Summary and Recommendations
1) Both performance-based outcome measures are feasible and easy to administer.
Compared to other recommended tests (40MFWT, Stair Climb Test), these
require little equipment and time to administer. These measures capture aspects
of function that are important for individuals following TKA and assist both
clinician and patient in realizing change has occurred and not just relying on selfreport and impairment measures which may not fully capture functional change.

2) This study explored the measurement properties of the tests in the first 12 weeks
following TKA. There is a need to continue to measure these tests further out in
the recovery process. This may also assist in implementation of rehabilitation
guidelines where discharge from physiotherapy was based more on function than
time.
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Appendix A - Letter of Information and Consent
Reliability and Validity of Two Performance Based Outcome Measures in
Rehabilitation Following Total Knee Arthroplasty
You are being invited to voluntary participate in this research study as you have recently
had a total knee replacement at London Health Science Centre – University Hospital.
This letter of information describes the research study and your role as a participant.
The purpose of this letter is to provide you with information required for you to make an
informed decision regarding participation in this research. Please read this form
carefully. Do not hesitate to ask anything about the information provided. The study
supervisor, Dr. Trevor Birmingham, or co-investigator, Jen Van Bussel describe the
study and answer any questions you may have. This project is part of the requirements of
a Master of Science degree for Jen Van Bussel, who will be collecting the data.
Study Purpose
The purpose of this study is to determine the reliability (precision) and validity
(accuracy) of the 30 Second Chair Stand Test (30 CST) and 10 Metre Walk Test (10
MWT) during rehabilitation in patients following total knee arthroplasty (TKA). Using
reliable and valid outcome measures during rehabilitation will help evaluate
improvements in physical function and assist in making decision regarding treatment.
Procedure
If you choose to participate in the study, you will be asked to fill out the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC) and complete the 30 CST
and 10 MWT as part of your standard physiotherapy assessment today. These measures,
along with the Global Rating of Change (GRC) will be repeated as part of a standard
assessment during your scheduled follow-up visits with your physiotherapist at 6 weeks
and 12 weeks following surgery. Study participation involves you attending two extra
sessions where you will be asked to repeat the 30 CST and 10 MWT. These sessions will
occur 24-48 hours after your 6-week and 12-week physiotherapy follow-up visit. These
sessions will take approximately 10 minutes of your time to complete.
Risks
The perceived risks of participation are minimal. As with any test of physical function
that requires you to be standing or walking there is a risk of falling. Allowing you to use
any gait aid you require during the 10 MWT will control this risk. Furthermore, during
the 30 CST and 10 MWT the tester will remain in close proximity to you to provide
assistance if required.
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Completion of the 30 CST and 10 MWT may cause a temporary increase in symptoms,
which is similar to the risk associated with any physiotherapy session. You are in
complete control of all aspects of these tests, and may stop at any point if you choose.
Personal data will be gathered for this study. There is a risk for breaching confidentiality
of this information; however procedures are set in place to minimize this risk (see below).
Benefits and Compensation
There are no direct benefits to you as a result of participation in this study. Participation
in this study may help physiotherapists in the future select reliable and valid outcome
measures to use during rehabilitation following TKA. In turn this will help future
patients, physiotherapists and surgeons measure true functional change and assist in
clinical decision making.
Reimbursement
You will be reimbursed for parking expenses accrued during the five session, as outlined
above, when testing will occur.
Voluntary Participation
Your participation in this study is voluntary. You may refuse to participate or
discontinue your participation at any time without affecting the medical care being
provided to you in any way. Should you choose to withdraw, information collected will
only be done as part of your standard assessment and not used in this study. The deidentified data you have contributed to that point may be used to help answer our
research question.
Confidentiality
Your confidentiality will be respected. You will be given an identification number, by
your physiotherapist, to use with your data collection forms. All information collected
for this study will be kept confidential and identified by this number. All information
collected will be stored in a locked cabinet and entered onto a secure password protected
server at University Hospital. A list linking your identification number with your name
will be kept on a secure password protected server at University Hospital, separate from
your study file. All information will be kept in a secure and confidential location for a
minimum of 15 years.
The results of this study may be used in presentations or published in a peer reviewed
scientific journal. Only group averages will be reported and your name and identity will
not be disclosed.
Qualified representatives of the Lawson Quality Assurance Education Program may look
at your medical/clinical study records at the site where those records are held, for quality
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assurance (to check that the information collected for the study is correct and follows
proper laws and guidelines).
You will be given a copy of this letter of information and consent form once it has been
signed. You do not waive any legal rights by signing the consent form. Representatives
of the University of Western Ontario Health Sciences Research Ethics Board my contact
you or require access to your study-related records to monitor the conduct of the research.
If you have any questions about your rights as a research participant or the conduct of this
study, you may contact the Patient Experience Office at LHSC. or access the online form
at: https://apps.lhsc.on.ca/?q=forms/patient-experiencecontact-form.
We thank you in advance for considering participation in this study.
Sincerely,
Dr. Trevor Birmingham PT, PhD
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Consent Form
Reliability and Validity of Two Performance Based Outcome Measures in
Rehabilitation Following Total Knee Arthroplasty

I have read the letter of information, have had the nature of the study explained to me and
I agree to participate. All questions have been answered to my satisfaction.

Participant name (print)

Participant signature

Date

Person obtaining consent (print)

Signature of person obtaining consent

Date
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Appendix B – Data Collection Form
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Appendix C – Performance Based Outcome Measures
Performance – Based Outcome Measures of Function
30 Second Chair Stand Test (30 CST)
The 30 CST assesses functional lower extremity strength and dynamic balance through
an evaluation of the ability to rise from a chair and sit back down repeatedly over 30
seconds (Bennell, 2011). The test is easy to administer and requires the use of a
stopwatch and straight back chair with a 17-inch seat height without arms. The test has
demonstrated both reliability and validity in those awaiting joint replacement surgery of
the hip or knee (Gill 2008; 2012).
10 Metre Walk Test (10 MWT)
A self-paced walk test is used in many groups, including those with hip and knee OA.
Gait speed has been established as a responsive and predictive measure for multiple
patient populations (Bennell, 2011). The test requires the participant to walk as fast as
they can, safely, over a distance of 10 metres. Gait aids may be used as required during
the test and use will be noted by the tester.
Protocol for the 30 Second Chair Stand Test
Patient Set Up
1.
2.
3.
4.
5.

Use a chair with a 17-inch seat height.
Place the chair against a wall to prevent it from moving.
Sit the patient comfortably in the middle of the chair.
Allow the patient to position their feet where they are comfortable.
Ask them to cross their arms across their chest.

Instructions to Patient
1. “This test looks at how many times you can stand and sit from a chair in 30
seconds.”
2. “If you do not fully stand or sit down so that your bottom touches the seat, that
repetition will not be counted.”
3. Demonstrate movement.
4. Allow one practice stand by the patient.
5. “When I say “GO”, I want you to stand up and sit down as many times as you can
in 30 seconds.”
6. “If you have pain that becomes too uncomfortable, you are allowed to stop the
test.”
7. “Do you understand what you need to do?”
8. “Are you ready?”
9. “Ready, set GO.”
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General Guidelines
1. If the patient is more than halfway up at the end of 30 seconds, it counts as a full
stand.
2. Do not offer any encouragement before or after each test other than “well done”.
3. If the patient expresses concern about performing a task, tell them to “do the best
that you can”.
(Adapted from: Gill and McBurney, 2008, p.151)
Protocol for the 10 Metre Walk Test
Patient Set Up
1. Mark out a 14-metre walkway with lines at 0m, 2m, 12m and 14m.
2. Instruct the patient to stand with toes touching the line at the 0m mark.
Instructions to Patient
1. “I am going to time how fast you can walk 10 metres”
2. “I want you to go as fast as you can safely walk. You will walk from the yellow
line to the other yellow line at the end of the walkway.”
3. Demonstrate the test and show the patient where the end line is.
4. “I want you to start when I say “GO”, and I will give you a “Ready, Set, GO””
5. “If you have pain that becomes too uncomfortable, you are allowed to stop the
test”
6. “Do you understand what you need to do?”
7. “Are you ready?”
8. “Ready, set, GO”
General Guidelines
1. Timing: start the stopwatch as the first part of the patient’s trunk or foot crosses
the 2m-mark. This allows for acceleration of gait speed to occur prior to time
starting. Stop the stopwatch as the first part of their trunk or foot crosses the
12m-mark. This will eliminate the effect of deceleration on test results.
2. Walk a pace behind the patient to avoid influencing pace but be close enough to
ensure safety.
3. The patient can use their usual and most appropriate gait aid.
4. Do not offer any encouragement before or after the test other than “well done”.
5. If a patient expresses concern about performing the task, tell them to “do their
best”.
(Adapted from: Gill and McBurney, 2008, p.151)
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Appendix D – WOMAC
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Appendix E – Global Rating of Change Scale - Pain
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Appendix F – Global Rating of Change Scale - Function

74

Appendix G – Ethics Approval
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